Clinical Characteristics of Patients With Anti-Jo-1 Antibodies
Linda M. Mileti(University of Chicago), Nadera Sweiss(University of Illinois Chicago), Mary E. Strek(University of Chicago), Timothy B. Niewold(Hospital for Special Surgery), James J. Curran(University of Chicago)
Cited by 55
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
<i>TOLLIP</i> , <i>MUC5B</i> , and the Response to <i>N</i> -Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2015|358
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2019|343
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
|Nature Genetics|2011|284